Targeting miR-29a-3p to thrombospondin 2 (THBS2) in a mouse model of MCT-induced PAH and cardiac remodeling resulted in reduced cardiac fibroblast activation and activation of the pro-fibrotic pathway. The gene discussed is THBS2; the disease is pulmonary arterial hypertension.